Studies from Akershus University Hospital Update Current Data on Limbic Encephalitis (Case Report: Limbic encephalitis following treatment with durvalumab for small-cell lung cancer).
In: Immunotherapy Weekly, 2023-10-31, S. 1342
serialPeriodical
Zugriff:
Keywords: Antibodies; Autoimmunity; Blood Proteins; Brain Diseases and Conditions; Cancer; Central Nervous System Diseases and Conditions; Central Nervous System Infections; Central Nervous System Viral Diseases and Conditions; Drugs and Therapies; Durvalumab Therapy; Encephalitis; Health and Medicine; Immunoglobulins; Immunology; Immunotherapy; Limbic Encephalitis; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Monoclonal Antibodies; Nervous System Paraneoplastic Syndromes; Neurodegenerative Diseases and Conditions; Oncology; Pharmaceuticals; Proteins; Virus Diseases and Conditions EN Antibodies Autoimmunity Blood Proteins Brain Diseases and Conditions Cancer Central Nervous System Diseases and Conditions Central Nervous System Infections Central Nervous System Viral Diseases and Conditions Drugs and Therapies Durvalumab Therapy Encephalitis Health and Medicine Immunoglobulins Immunology Immunotherapy Limbic Encephalitis Lung Cancer Lung Diseases and Conditions Lung Neoplasms Monoclonal Antibodies Nervous System Paraneoplastic Syndromes Neurodegenerative Diseases and Conditions Oncology Pharmaceuticals Proteins Virus Diseases and Conditions 1342 1342 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New study results on limbic encephalitis have been published. Antibodies, Autoimmunity, Blood Proteins, Brain Diseases and Conditions, Cancer, Central Nervous System Diseases and Conditions, Central Nervous System Infections, Central Nervous System Viral Diseases and Conditions, Drugs and Therapies, Durvalumab Therapy, Encephalitis, Health and Medicine, Immunoglobulins, Immunology, Immunotherapy, Lung Cancer, Lung Diseases and Conditions, Lung Neoplasms, Monoclonal Antibodies, Nervous System Paraneoplastic Syndromes, Limbic Encephalitis, Neurodegenerative Diseases and Conditions, Oncology, Pharmaceuticals, Proteins, Virus Diseases and Conditions. [Extracted from the article]
Copyright of Immunotherapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Studies from Akershus University Hospital Update Current Data on Limbic Encephalitis (Case Report: Limbic encephalitis following treatment with durvalumab for small-cell lung cancer).
|
---|---|
Zeitschrift: | Immunotherapy Weekly, 2023-10-31, S. 1342 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1090-8625 (print) |
Sonstiges: |
|